1.8580
0.0000
(0.00%)
At close: April 10 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Sep 2017) | Next Qtr. (Jan 1970) | Current Year (2017) | Next Year (1970) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Sep 2017) | Next Qtr. (Jan 1970) | Current Year (2017) | Next Year (1970) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
Currency in USD | 9/30/2016 | 12/31/2016 | 3/31/2017 | 6/30/2017 |
---|---|---|---|---|
EPS Est. | -5 | -4.2 | -2.2 | -1.4 |
EPS Actual | -3.6 | -4 | -2.8 | -2 |
Difference | 1.4 | 0.2 | -0.6 | -0.6 |
Surprise % | 28.00% | 4.76% | -27.27% | -42.86% |
EPS Trend
Currency in USD | Current Qtr. (Sep 2017) | Next Qtr. (Jan 1970) | Current Year (2017) | Next Year (1970) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Sep 2017) | Next Qtr. (Jan 1970) | Current Year (2017) | Next Year (1970) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 1 | -- |
Up Last 30 Days | -- | -- | 1 | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
HRGN | -- | -- | -- | -- |
S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Related Tickers
1541.HK IMMUNEONCO-B
5.130
+3.64%
AKESF Akeso, Inc.
9.30
0.00%
SLN Silence Therapeutics plc
2.1900
+0.46%
GLYC GlycoMimetics, Inc.
0.1946
+1.25%
9926.HK Akeso, Inc.
81.550
+9.98%
TIL Instil Bio, Inc.
14.18
-6.22%
MGNX MacroGenics, Inc.
1.2500
-1.57%
CARM Carisma Therapeutics, Inc.
0.1990
+0.66%
LEGN Legend Biotech Corporation
31.28
-2.49%
NUVB Nuvation Bio Inc.
1.7500
-2.23%